WebFor fully gold open access journals of the 10 largest publishers the weighted mean APC is US$2,371 and the highest APC is US$8,900 For hybrid journals from the 10 largest publishers, the weighted mean APC is US$3,410 while the highest APC is US$11,390 For a subscription article, the range of revenue is between US$4,000 and US$9,000
Frontiers in Pharmacology - Impact Factor, Overall Ranking
WebApr 11, 2024 · Frontiers in Pharmacology 5.988 Impact Factor 6.6 CiteScore 187,923 Citations Submit your research Start your submission and get more impact for your research by publishing with us. Author guidelines Ready to publish? Open access publisher of peer-reviewed scientific articles across the entire … Articles - Frontiers in Pharmacology Research Topics - Frontiers in Pharmacology Editorial board - Frontiers in Pharmacology While Frontiers evaluates articles using objective criteria, rather than impact or … Open Access provides free and immediate online access to the scholarly literature … Impact and progress Frontiers' impact 2024 Progress Report All progress reports ... Table 1: Frontiers' APCs are structured in four categories, depending on the … Explores all aspects of pre-clinical and clinical pharmacology of drugs for the … Search - Frontiers in Pharmacology WebApr 13, 2024 · ZyVersa Therapeutics Announces Review Article Published in Frontiers in Pharmacology Addressing Microglial Inflammatory Activity as a Pharmacological Target in Mild Cognitive Impairment and Alzheimer’s Disease. ... nor can ZyVersa assess the impact of each such factor on the business or the extent to which any factor, or combination of ... etsy credit card points
Inflammation Home - Springer
WebAims & Scope. Environmental Toxicology and Pharmacology publishes the results of studies concerning toxic and pharmacological effects of (human and veterinary) drugs and of environmental contaminants in animals and man. Areas of special interest are: molecular mechanisms of toxicity, biotransformation and toxicokinetics (including toxicokinetic ... Web23 hours ago · WESTON, Fla., April 13, 2024 (GLOBE NEWSWIRE) — ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, announces publication of a review article in Frontiers in Pharmacology … WebJul 6, 2024 · Frontiers in Pharmacology has an Impact Factor of 4.418 and is the #2 most cited open-access journal in Pharmacology. [...] Quality and Impact Analysis: Frontiers in Physiology November 25, 2015 // 4 Comments Frontiers in Physiology an Impact Factor of 4.031 and is the #1 most cited open-access Physiology journal. [...] firewall optimization options pfsense